Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The American experience with desmopressin

D A Bloom1

  • 1University of Michigan, Ann Arbor 48109-0330.

Clinical Pediatrics
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

A new drug, desmopressin acetate, effectively treats childhood nocturnal enuresis by mimicking vasopressin. This medication has proven safe and is a leading treatment option globally.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chrysaora achlyos, a Remarkable New Species of Scyphozoan from the Eastern Pacific.

The Biological bulletin·2017
Same author

The natural history of the multicystic dysplastic kidney--is limited follow-up warranted?

Journal of pediatric urology·2014
Same author

Two-Step Fowler-Stephens orchiopexy for intra-abdominal testes: a 28-year single institution experience.

The Journal of urology·2013
Same author

EUTUBS: a mnemonic for the complete endoscopic examination of the lower urinary tract.

West African journal of medicine·2003
Same author

Overactive bladder: paediatric aspects.

BJU international·2002
Same author

Sales and science: changing patterns of pharmaceutical and medical device advertising in peer reviewed urology publications, 1975-2000.

The Journal of urology·2001

Area of Science:

  • Pediatric Endocrinology
  • Pharmacology
  • Urology

Background:

  • Childhood nocturnal enuresis is often linked to insufficient vasopressin levels.
  • Previous treatments were less effective, prompting research into new therapeutic strategies.

Purpose of the Study:

  • To evaluate the efficacy and safety of desmopressin acetate for treating nocturnal enuresis in children.
  • To establish desmopressin acetate as a primary treatment for this condition.

Main Methods:

  • Clinical trials were conducted in Europe and the United States.
  • Desmopressin acetate was administered at dosages ranging from 5 to 40 micrograms.

Main Results:

  • Desmopressin acetate demonstrated significant efficacy in treating childhood nocturnal enuresis.

Related Experiment Videos

  • The drug's safety profile was well-established across study populations.

    • Conclusions:

    • Desmopressin acetate is a highly effective and safe pharmacologic option for childhood nocturnal enuresis.
    • It is recognized as a first-line treatment by physicians globally.